Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial

被引：0
作者：
T. J. Vogl
M. C. Langenbach
R. Hammerstingl
M. H. Albrecht
A. R. Chatterjee
T. Gruber-Rouh
机构：
[1] Johann Wolfgang Goethe University,Institute for Diagnostic and Interventional Radiology
[2] Medical University of South Carolina,Department of Radiology and Radiological Science
来源：
Hepatology International | 2021年 / 15卷
关键词：
Hepatocellular carcinoma; TACE; Lipiodol; DSM; Mitomycin C; Magnetic resonance imaging; Response; Survival; Tumor volume; Necrotic area;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：685 / 694
页数：9
相关论文
共 50 条
  • [1] Evaluation of two different transarterial chemoembolization protocols using Lipiodol and degradable starch microspheres in therapy of hepatocellular carcinoma: a prospective trial
    Vogl, T. J.
    Langenbach, M. C.
    Hammerstingl, R.
    Albrecht, M. H.
    Chatterjee, A. R.
    Gruber-Rouh, T.
    HEPATOLOGY INTERNATIONAL, 2021, 15 (03) : 685 - 694
  • [2] Degradable Starch Microspheres Transarterial Chemoembolization with or without Lipiodol for Liver Metastases from Pancreatic Cancer: A Prospective Randomized Trial
    Vogl, Thomas J.
    Lilienthal, Charlotte
    Gruber-Rouh, Tatjana
    Afraz, Zahra
    Adwan, Hamzah
    CANCERS, 2023, 15 (21)
  • [3] Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study
    Gruber-Rouh, Tatjana
    Schmitt, Cornelia
    Naguib, Nagy N. N.
    Nour-Eldin, N. A.
    Eichler, Katrin
    Beeres, Martin
    Vogl, Thomas J.
    BMC CANCER, 2018, 18
  • [4] Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study
    Tatjana Gruber-Rouh
    Cornelia Schmitt
    Nagy N. N. Naguib
    N. A. Nour-Eldin
    Katrin Eichler
    Martin Beeres
    Thomas J. Vogl
    BMC Cancer, 18
  • [5] Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival
    Kirchhoff, Timm D.
    Bleck, Joerg S.
    Dettmer, Arne
    Chavan, Ajay
    Rosenthal, Herbert
    Merkesdal, Sonja
    Frericks, Bernd
    Zender, Lars
    Malek, Nisar P.
    Greten, Tim F.
    Kubicka, Stefan
    Manns, Michael P.
    Galanski, Michael
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2007, 6 (03) : 259 - 266
  • [6] Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival
    Timm D Kirchhoff
    Joerg S Bleck
    Arne Dettmer
    Ajay Chavan
    Herbert Rosenthal
    Sonja Merkesdal
    Bernd Frericks
    Lars Zender
    Nisar P Malek
    Tim F Greten
    Stefan Kubicka
    Michael P Manns
    Michael Galanski
    Hepatobiliary&PancreaticDiseasesInternational, 2007, (03) : 259 - 266
  • [7] Repeated Transarterial Chemoembolization with Degradable Starch Microspheres (DSMs-TACE) of Unresectable Hepatocellular Carcinoma: A Prospective Pilot Study
    Orlacchio, Antonio
    Chegai, Fabrizio
    Francioso, Simona
    Merolla, Stefano
    Monti, Serena
    Angelico, Mario
    Tisone, Giuseppe
    Mannelli, Lorenzo
    CURRENT MEDICAL IMAGING REVIEWS, 2018, 14 (04) : 637 - 645
  • [8] Degradable starch microspheres transarterial chemoembolization (DSM-TACE) in patients with unresectable hepatocellular carcinoma: results from the Prospective Multicenter Observational HepaStar Trial
    Collettini, Federico
    Andrasina, Tomas
    Reimer, Peter
    Schima, Wolfgang
    Stroszczynski, Christian
    Lamprecht, Yasmina
    Auer, Timo Alexander
    Rohan, Tomas
    Wildgruber, Moritz
    Gebauer, Bernhard
    Masthoff, Max
    EUROPEAN RADIOLOGY, 2024,
  • [9] Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma
    Langenbach, Marcel C.
    Vogl, Thomas J.
    Said, Gulia
    Scholtz, Jan-Erik
    Hammerstingl, Renate
    Gruber-Rouh, Tatjana
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (03) : 196 - 202
  • [10] Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)
    Steinberg-Vorhoff, Hannah L.
    Tropotel, Andriana
    Theysohn, Jens M.
    Schaarschmidt, Benedikt
    Haubold, Johannes
    Jeschke, Matthias
    Jochheim, Leonie
    Ludwig, Johannes M.
    CANCERS, 2025, 17 (04)
12345